Kelly Grein
Family · Ste Genevieve, MONPI 1407455421
Payments from drug & device makers
Across 235 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$902
- Lilly USA, LLC$673
- Amgen$542
- Pfizer$324
- Novartis$308
- Novo Nordisk$294
- plus $1K from 20 others
What the payments were for
- Food & beverage$4,13398%
- Education$772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 51 | $902 |
| Lilly USA, LLC | 37 | $673 |
| Amgen | 29 | $542 |
| Pfizer | 17 | $324 |
| Novartis | 19 | $308 |
| Novo Nordisk | 18 | $294 |
| Johnson & Johnson(2 entities) | 14 | $275 |
| Merck | 11 | $159 |
| AstraZeneca(2 entities) | 7 | $114 |
| Mallinckrodt Hospital Products Inc. | 4 | $109 |
| GSK | 4 | $71 |
| ANI Pharmaceuticals, Inc. | 2 | $50 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $48 |
| Sumitomo Pharma America, Inc. | 3 | $46 |
| Organon | 2 | $40 |
| Radius Health, Inc. | 2 | $40 |
| Boston Scientific | 1 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Biohaven Pharmaceuticals, Inc. | 1 | $24 |
| Viatris Specialty LLC | 1 | $22 |
| Grifols USA, LLC | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Urovant Sciences Inc | 1 | $12 |
How this compares
$4,210 in reported general payments places this provider in the 90th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 33 | $32,952 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $16,877 |
| OzempicSemaglutide | 16 | $15,641 |
| MounjaroTirzepatide | 13 | $13,179 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $10,020 |
| LinzessLinaclotide | 15 | $8,127 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $5,369 |
| Gabapentin | 150 | $2,123 |
| LevemirInsulin Detemir | 12 | $1,221 |
| Atorvastatin Calcium | 192 | $962 |
| Hydroxychloroquine Sulfate | 23 | $815 |
| Omeprazole | 45 | $625 |
| Fluticasone Propionate | 41 | $560 |
| Celecoxib | 28 | $519 |
| Ropinirole Hcl | 23 | $475 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $71 | $22,24540 claims |
| Novo NordiskOzempic, Levemir | $294 | $16,86228 claims |
| Lilly USA, LLCMounjaro | $673 | $13,17913 claims |
| AstraZenecaBreztri Aerosphere | $114 | $10,02016 claims |
| AbbVieLinzess | $902 | $8,12715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,812 family providers in Missouri.
Other family in Ste Genevieve
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.